Cargando…

Acircadian rhythm-related gene signature for predicting survival and drug response in HNSC

Head and neck squamous cell carcinoma (HNSC) represents one of the most common malignant carcinomas worldwide. Because the 5-year survival rate of patients with HNSC is poor, it is necessary to develop an effective signature for predicting the risk of HNSC. To identify a circadian rhythm (CR)-relate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chuan, Dang, Dan, Wang, Hongrui, Shi, Shuyou, Dai, Jiayu, Yang, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729285/ https://www.ncbi.nlm.nih.gov/pubmed/36505439 http://dx.doi.org/10.3389/fimmu.2022.1029676

Ejemplares similares

Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer
por: Chuang, Yi-Hsuan, et al.
Publicado: (2023)

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB
por: Li, Mingyu, et al.
Publicado: (2023)

Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas – comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients
por: Knebel, Moritz, et al.
Publicado: (2023)

Novel CAF-identifiers via transcriptomic and protein level analysis in HNSC patients
por: Dwivedi, Nehanjali, et al.
Publicado: (2023)

Machine learning with the TCGA-HNSC dataset: improving usability by addressing inconsistency, sparsity, and high-dimensionality
por: Rendleman, Michael C., et al.
Publicado: (2019)

Exploring ALDH2 expression and immune infiltration in HNSC and its correlation of prognosis with gender or alcohol intake
por: Yao, Senbang, et al.
Publicado: (2022)

Multifunctionalized hydrogels foster hNSC maturation in 3D cultures and neural regeneration in spinal cord injuries
por: Marchini, Amanda, et al.
Publicado: (2019)

Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis
por: Huang, Chunli, et al.
Publicado: (2022)

USP7- and PRMT5-dependent G3BP2 stabilization drives de novo lipogenesis and tumorigenesis of HNSC
por: Wang, Nan, et al.
Publicado: (2023)

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer
por: Zhu, Weian, et al.
Publicado: (2023)

The effect of citalopram treatment on amyloid-β precursor protein processing and oxidative stress in human hNSC-derived neurons
por: Elsworthy, R. J., et al.
Publicado: (2022)

A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing
por: Xiang, Xiaoqing, et al.
Publicado: (2023)

Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
por: Tong, Shiao, et al.
Publicado: (2022)

Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
por: Zeng, Yu, et al.
Publicado: (2022)

Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients
por: Chen, Hualin, et al.
Publicado: (2023)

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
por: Chen, Rui-Lian, et al.
Publicado: (2020)

Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019
por: Dai, Jiayu, et al.
Publicado: (2022)

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
por: Wu, Xiangkun, et al.
Publicado: (2020)

A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab
por: Lin, Jiamao, et al.
Publicado: (2021)

An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment
por: Abou Khouzam, Raefa, et al.
Publicado: (2021)

Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer
por: Xu, Yan, et al.
Publicado: (2023)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
por: Zhou, Yi, et al.
Publicado: (2023)

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma
por: Chen, Shujia, et al.
Publicado: (2022)

Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer
por: Cui, Hanxiao, et al.
Publicado: (2023)

Screening and Validation of the Hypoxia-Related Signature of Evaluating Tumor Immune Microenvironment and Predicting Prognosis in Gastric Cancer
por: Pei, Jun-Peng, et al.
Publicado: (2021)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with Wilms tumour
por: Tian, Xiao-Mao, et al.
Publicado: (2022)

Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

An estrogen response-related signature predicts response to immunotherapy in melanoma
por: Lin, Min, et al.
Publicado: (2023)

Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma
por: Zhou, Renlong, et al.
Publicado: (2022)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
por: Huang, Jihong, et al.
Publicado: (2022)

Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma
por: Yan, Xin, et al.
Publicado: (2022)

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
por: Zhao, Zidan, et al.
Publicado: (2023)

Predicting the prognosis in patients with sepsis by a pyroptosis-related gene signature
por: Liang, Shuang, et al.
Publicado: (2022)

Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients
por: Zhang, Zi-jian, et al.
Publicado: (2023)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Xuewen, et al.
Publicado: (2022)

A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma
por: Tian, Xiao-Mao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n9lqvj30ssjtdllolbeg836cpn